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ABSTRACT
Objective: This study uses a modelling approach to
compare the potential impact of future risk factor
scenarios relating to smoking, physical activity levels,
dietary salt, saturated fat intake, mean body mass index
(BMI) levels, diabetes prevalence and fruit and
vegetable (F&V) consumption on future coronary heart
disease (CHD) mortality in Turkey for year 2025.
Design: A CHD mortality model previously developed
and validated in Turkey was extended to predict
potential trends in CHD mortality from 2008 to 2025.
Setting: Using risk factor trends data from recent
surveys as a baseline, we modelled alternative
evidence-based future risk factor scenarios (modest/
ideal scenarios). Probabilistic sensitivity analyses were
conducted to account for uncertainties.
Subject: Projected populations in 2025 (aged 25–84)
of 54 million in Turkey.
Results: Assuming lower mortality, modest policy
changes in risk factors would result in ∼25 635 (range:
20 290–31 125) fewer CHD deaths in the year 2025;
35.6% attributed to reductions in salt consumption,
20.9% to falls in diabetes, 14.6% to declines in
saturated fat intake and 13.6% to increase in F&V
intake. In the ideal scenario, 45 950 (range: 36 780–
55 450) CHD deaths could be prevented in 2025.
Again, 33.2% of this would be attributed to reductions
in salt reduction, 19.8% to increases in F&V intake,
16.7% to reductions in saturated fat intake and 14.0%
to the fall in diabetes prevalence.
Conclusions: Only modest risk factor changes in salt,
saturated/unsaturated fats and F&V intake could
prevent around 16 000 CHD deaths in the year 2025 in
Turkey, even assuming mortality continues to decline.
Implementation of population-based, multisectoral
interventions to reduce salt and saturated fat
consumption and increase F&V consumption should
be scaled up in Turkey.
BACKGROUND
Cardiovascular diseases (CVDs) are the
leading cause of death in the world.1
Low-income and middle-income countries
are disproportionally affected from the
burden of CVDs; more than 80% of global
CVD deaths take place in these countries.1
The main types of CVDs are coronary heart
disease (CHD) and stroke, and it is estimated
that 80% of premature (<80 years old)
deaths from these diseases can be pre-
vented.2 3 Turkey is a developing
upper-middle-income country according to
the World Bank with a population of ∼74
million.4 According to the National Burden
of Disease Study, 8% of the total burden of
disease was due to CHD in 2004, and CHD
was the leading cause of morbidity among
adults in Turkey.5 CHD prevalence was 5.0%
in men and 2.6% in women over the age of
20 in 2011.6 The burden of CVDs is rising
rapidly all over the world as a result of popu-
lation growth, ageing and due to increases in
major CVD risk factors.1 The major modiﬁ-
able risk factors of CVDs are diabetes
Strengths and limitations of this study
▪ This is the first comprehensive modelling study
that examines the impact of changes in multiple
risk factors and healthy food consumption on
coronary heart disease (CHD) mortality trends in
Turkey, and a cumulative adjustment for simul-
taneous risk factor improvements (since a CHD
death can only be prevented once) was made.
▪ The demographic information was obtained from
the census data that covered the whole country;
the risk factor trends were obtained from national
epidemiological studies.
▪ In the Turkish IMPACT model, we assessed the
CIs by using rigorous probabilistic sensitivity
analyses which systematically examine the influ-
ence of these uncertainties and the assumptions
used in the studies. We used plausible estimates
for changes in risk factor scenarios.
▪ The model included only those adults aged 25–
84 years because of very limited data in older
age groups. The lag times were not explicitly
considered in this model.
▪ We measured only deaths from CHD and disre-
garded ‘competing causes’ such as cancer.
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mellitus (DM), high blood pressure, high saturated fat
intake, hyperlipidaemia, smoking, physical inactivity,
obesity and low fruit and vegetable (F&V) intake.7 Many
population-based interventions have been proven to be
effective for reducing CVD mortality.8 For example,
decreasing saturated fat intake by 1% of total energy
reduces CHD deaths by 3.6% due to the decline in
blood cholesterol; decreasing salt intake by 1 g/day
reduces CHD deaths by 3.4% due to decline in blood
pressure; and increasing F&V intake by 1 portion/day
results in a 4.0% reduction in CHD deaths due to
declines in blood pressure and cholesterol.9 10
It has been estimated that ∼24 000 CHD deaths were
prevented or postponed by risk factor changes in Turkey
between 1995 and 2008, mainly due to decreasing
trends in systolic blood pressure (SBP) levels and
smoking rates.11 However, increases in obesity and dia-
betes were estimated to have resulted in over 9000 add-
itional deaths in 2008.11 Recently, the Turkish Ministry
of Health (MoH) prepared strategies and action plans
in order to reduce the burden of cardiovascular risk
factors in Turkey,12 but this strategic plan is not compre-
hensive and evidence based. Modelling studies are
useful to determine the policy priorities through an
evidence-based approach.
The aim of this study is to appraise the potential
reductions in CHD mortality achievable by modest and
ideal decreases in smoking, diabetes, physical inactivity,
body mass index (BMI), consumption of saturated fat,
salt and increases in consumption of F&V in Turkey by
year 2025.
METHODS
The IMPACT model
The IMPACT model for Turkey has been previously pub-
lished to explain past trends in CHD mortality (1995–
2008). This model was validated by comparing the
model-predicted CHD death rates in 2008 with observed
CHD deaths (International Classiﬁcation of Diseases,
10th revision (ICD-10) codes I20–I25) in 2008, stratiﬁed
by age and gender.11 The model has also recently been
validated for forward prediction in European popula-
tions.13 Appendices detailing the methods and data
sources used for this model have already been published
and are available from here (http://www.biomedcentral.
com/content/supplementary/1471-2458-13-1135-s1.docx).
We summarise in brief the data sources below.
Microsoft Excel program was used in order to implement
the model.
Estimating future CHD mortality to 2025
Future CHD mortality in 2025 was estimated using two
approaches, recognising the uncertainty inherent in
future predictions. First, ‘lower mortality’ values for 2025
were determined by ﬁtting age-speciﬁc and gender-
speciﬁc negative exponential decay models on historical
CHD mortality rates between 1995 and 2008 using an
iterative non-linear least squares model: y=a×exp
(−b×year), where a is the CHD mortality rate and b is
the constant decay rate. Second, a ‘no mortality change’
estimate for CHD mortality in 2025 was calculated using
an indirect standardisation approach, multiplying age-
speciﬁc and gender-speciﬁc mortality rates for 2008 by
the projected population for each 10-year age group in
the year 2025.
Data sources
All data were stratiﬁed by gender and 10-year age groups
for persons aged 25–84 years. Information on population,
mortality and demographic changes was obtained from
the census (1995) and Address Based Population
Registration System (2008) of the Turkish Statistical
Institute (TURKSTAT).14 Although the TURKSTAT data
collection method changed between 1995 and 2008, popu-
lation projections based on the census were very close to
the population of address-based registration in 2008.15 We
obtained estimates of the projected population in 2025
from the State Planning Organization in Turkey.16
For the baseline year of the prediction model (2008),
an extensive search was carried out for published and
unpublished results.11 Population risk factor trend data,
including SBP, total cholesterol, hypertension and
smoking prevalence, were obtained from nationally rep-
resentative surveys.17–20
Current and projected population-level trend data for
diabetes and BMI were obtained from another pub-
lished model for Turkey.17 18 21 Physical inactivity and
F&V consumption trend data were generated by using
information from national and regional surveys.6 22–24
All risk factor data trends for year 2025 were projected
by using the available data and applying linear regres-
sion method by year and related prevalence rates assum-
ing the same trend will continue in the future.
Method of estimating trends in mortality for a given risk
factor change
Relative risks (RRs) estimated by expert working groups
for the WHO’s Global Burden of Disease 2001 Study
were used for changes in smoking, physical activity25 and
diabetes.26 Regression coefﬁcients from meta-analyses of
cohort studies were used to quantify the effect of redu-
cing salt intake on the change in mean SBP in the popu-
lation27 and on the effect of replacing dietary saturated
fat intake by either polyunsaturated fats or monounsatu-
rated fats.28 Regression coefﬁcients from meta-analyses
of cohort studies were also included in the model to
quantify the relationship between change in other risk
factors (SBP, total cholesterol, F&V consumption, BMI)
and change in CHD mortality.10 29–31
A population-attributable risk fraction (PARF)
approach was used to determine the number of deaths
prevented or postponed (DPPs) in 2025 resulting from
improvements in smoking, physical inactivity and dia-
betes trends. The PARF was calculated conventionally
for 2008 and 2025 as (P×(RR−1))/(1+P×(RR−1)),
2 Sahan C, et al. BMJ Open 2016;6:e011217. doi:10.1136/bmjopen-2016-011217
Open Access
group.bmj.com on July 11, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
where P is the prevalence of the risk factor and RR is
the relative risk for CHD mortality associated with the
individual risk factor. The number of deaths prevented
was calculated as the number of deaths in 2025 multi-
plied by the decrease in PARF between 2008 and 2025.
Premature deaths were deﬁned as deaths that occur
before a person reaches the age of 85.
The number of CHD deaths potentially prevented in
2025, as a result of improved levels of BMI, F&V con-
sumption, cholesterol and SBP in the population, was
then estimated as the product of the three variables: the
number of CHD deaths observed in 2008, the estimated
absolute change in that risk factor between 2008 and
2025 and the adjusted regression coefﬁcient quantifying
the independent relationship between population
change in a speciﬁc cardiovascular risk factor and the
consequent change in mortality from CHD.
Cumulative adjustment for risk factor changes done
simultaneously
CHD deaths are caused by multiple risk factors acting
simultaneously. Enumerating mortality changes from
risk factor trends should ideally therefore not use a
simple additive approach. Instead, the effects of risk
factor changes were jointly estimated using the cumula-
tive relative beneﬁt approach. This can be stated in the
following equation:
Cumulative relative benefit ¼
1 ðð1 relative reduction inmortality for risk factor AÞ
ð1relative reduction inmortality for risk factor BÞ  
ð1 relative reduction inmortality for risk factorNÞÞ;
where N is the total number of additional risk factors
(in this case 6 as in total we modelled 7). This approach
is explained with an example in the online supplemen-
tary appendix.
This cumulative effect of change in all risk factors over
the study period was calculated by age and gender. The
ratio of the cumulative effect to the corresponding addi-
tive effect was then calculated, yielding 72 adjustment
factors, which were used to scale down the additive DPPs
for each risk factor. These adjusted DPPs, summed over
all seven risk factors, then equalled the estimated total
combined DPPs, capturing the multiplicative net impact
of positive and adverse changes in risk factors. All risk
factor DPPs quoted in the results tables refer to the
adjusted DPPs.
Scenario design
When we evaluated CHD risk factor changes in Turkey
between 1995 and 2008,11 smoking prevalence and the
mean SBP decreased by 42% and 2%, respectively. In
the same period, diabetes prevalence and mean BMI
rose by 22% and 6%, respectively. Furthermore, there
was a little decrease in total cholesterol, physical inactiv-
ity and an increase in F&V consumption.32 Recently, the
MoH in Turkey developed strategic plans to control non-
communicable diseases. However, national targets for
cardiovascular risk factor reductions were not deﬁned
explicitly.12 The WHO set targets for reducing cardiovas-
cular risk factors in order to decrease premature deaths
from non-communicable diseases by 25% until 2025.33
The scenarios for 2025 were generated based on the
information on recent trends in CVD risk factors in
Turkey, from different surveys and targets set by the
WHO.33
1. Salt consumption: Average daily salt consumption in
Turkey decreased rapidly by 22% (from 18 to 15 g/day)
from 2008 to 2012.34 35 In many countries, the average
daily salt consumption varies between 9 and 12 g, and
the WHO recommends <5 g daily salt consumption.33
We therefore evaluated the impact of modest and ideal
changes in salt consumption, to 10 and 5 g/day,
respectively.
2. Saturated/unsaturated fat consumption: Reduction in
saturated fatty acid (SFA) consumption is a major
focus of dietary recommendations to reduce the con-
centration of plasma lipoprotein cholesterol frac-
tions.36 It is recommended that energy intake from
dietary SFA should not exceed 10%, and recom-
mended range for energy from total polyunsaturated
fatty acid (PUFA) can range between 6% and 11%.36
In a recent national nutrition survey in Turkey, the
percentage of total energy obtained from dietary SFA
and PUFA among adults over 20 was 12% and 9%,
respectively.37 The percentage of PUFA in the daily
energy intake is in the recommended range in Turkey.
Therefore, we only estimated the impact of reaching
recommended levels of SFA intake in the Turkish
population. Hence, we evaluated the impact of reach-
ing modest and ideal targets in energy from dietary
SFA of United Nations, 11% and 10%, respectively.
3. Physical inactivity: We estimated the impact of a 5%
and 10% relative reduction in the prevalence of
insufﬁcient physical activity, the global targets set by
the WHO in our modest and ideal scenario.33
a. BMI: It is estimated that mean BMI of Turkish popu-
lation (aged 25–84) will increase between 2008 and
2025, from 29.0 to 30.4 kg/m2.21 Finucane et al38 esti-
mated the mean BMI trends between 1980 and 2008
worldwide increased by ∼0.04 kg/m2 per year. Hence,
we estimated that the increase in BMI in 17 years will be
0.68 kg/m2 reaching to 29.7 kg/m2 in 2025. Hence, we
modelled a 0.7 unit or 2.3% decrease from the recent
trend in BMI in our modest scenario. In the ideal scen-
ario, we assumed that mean BMI of Turkish population
will not change by 2025, remaining at 29.0 kg/m2. As a
result, we modelled the beneﬁt of a 1.4 kg/m2 or 4.6%
reduction in mean BMI by 2025.
4. Diabetes: A recent US study reported that even if the
most effective population prevention strategy was
implemented, diabetes prevalence would still
increase by about 65% over the 20 years (between
2010 and 2030) due to population ageing and
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increasing BMI.39 For this reason, we assumed that
diabetes prevalence would be maximum 29% (10%
lower than that suggested by recent trends21) in 2025
in the ideal scenario and 31% in the modest scenario
(5% lower than suggested by recent trends).
5. Smoking: Smoking prevalence started to decline in
Turkey after the implementation of the Framework
Convention on Tobacco Control since 2008.
According to the Turkish Global Adult Tobacco
Survey (GATS) conducted in 2008 and 2012,
smoking prevalence decreased by 13% in adults.19
Therefore, we modelled the impact of a 30% relative
reduction in smoking prevalence by 202533 as
the ideal scenario and 15% relative reduction as the
modest scenario.
6. F&V consumption: There is enough evidence that F&V
consumption plays a role in the prevention of CVDs.
We examined the targets for F&V consumption set
out by the European Union (EU) and WHO, which
were 5 and 7 portions/day, ∼40% and 100% relative
increase, respectively.40 41
Risk factor changes in the base year 2008 and projec-
tions to 2025 under two assumptions (modest and ideal
scenarios) are presented as a summary in table 1.
Sensitivity analyses
Multivariate probabilistic sensitivity analyses using Monte
Carlo simulation were conducted for all assumptions
and variables. Distributions used for main input para-
meters in the model are presented in the online supple-
mentary appendix. The 95% credible estimates reported
are based on the 2.5th and 97.5th centiles of results gen-
erated from 1000 iterations of the model. The number
of DPPs was rounded to the nearest whole number;
maximum and minimum estimates are presented in the
tables and ﬁgures, but only the best estimate is pre-
sented in the text to aid clarity.
RESULTS
The projected population in 2025 (adults aged 25–84)
was 54 million in Turkey. Table 2 shows the estimated
CHD deaths prevented by achieving risk factor policy
targets (modest and ideal) for no mortality change scen-
ario in men and women. If we assume no mortality
change in 2025, modest changes in risk factor policy
could result in 47 140 (minimum 38 175; maximum
56 310) fewer CHD deaths, a reduction of ∼30% of the
number expected in 2025.
In both risk factor scenarios, ∼36.1–33.6% of the
fewer CHD deaths could be attributed to reductions in
salt intake, 13.6–15.6% to decreased saturated fat energy
consumption levels, 13.1–19.2% to increased F&V
consumption levels and 21.2–14.1% to decrease in dia-
betes prevalence if no mortality change occurs by 2025
(table 2, ﬁgure 1).
Table 3 shows the number of CHD deaths that are esti-
mated for the lower mortality change scenario for 2025.
Approximately 25 630–45 950 CHD deaths were pre-
vented or postponed by modest and ideal scenarios,
respectively.
If we assumed that mortality continued to decline and
applied ideal scenarios in major risk factors by 2025, the
breakdown of DPPs would be as follows:
A. Salt intake: Approximately 15 265 deaths will be pre-
vented or postponed, assuming relative decrease in
dietary salt intake by 70% (WHO target 5 g/day salt
intake).
B. Saturated/unsaturated fat: Approximately 7690 deaths
will be prevented or postponed, assuming absolute
decrease in per cent energy from dietary saturated fat
by 2% (target 10% energy from dietary saturated fat).
C. F&V consumption: Approximately 9095 deaths will be
prevented or postponed, assuming relative increase
in F&V consumption by 100% (target 7 portions/day
F&V intake).
Table 1 Risk factor changes in the base year 2008 and projections to 2025 under two assumptions (modest and ideal
scenarios)
Modest scenario Ideal scenario
Changes
(%) 2008 2025
Changes
(%) 2008 2025
Absolute smoking prevalence rate reduction 3.0 22% 19% 6.0 22% 16%
Relative decrease in dietary salt intake 40.0 18 g/day 10 g/day 70.0 18 g/day 5 g/day
Absolute diabetes prevalence rate reduction
from the recent trends
2.0 32% 30% 4.0 32% 28%
Relative decrease in mean BMI from the
recent trends
2.3 30.4% 29.7% 4.6 30.4% 29.0%
Absolute decrease in per cent energy from
dietary saturated fat
1.0 12% 11% 2.0 12% 10%
Relative increase in F&V consumption 40.0 3.5 portion/
day
5 portion/
day
100.0 3.5 portion/
day
7 portion/
day
Absolute physical inactivity prevalence
reduction
3.0 64% 61% 6.0 64% 58%
BMI, body mass index; F&V, fruit and vegetable.
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D. Diabetes: Approximately 6415 deaths will be prevented
or postponed, assuming absolute diabetes prevalence
rate reduction by 4% (target 10% lower than recent
trends).
E. BMI: Approximately 1555 deaths will be prevented or
postponed, assuming that relative decrease in mean
BMI value will be 4.6% (target a mean reduction in
BMI of 1.4 units in 17 years).
F. Smoking: Approximately 2025 deaths will be pre-
vented or postponed, assuming that absolute
smoking prevalence rate reduction will be 6% (30%
relative reduction by WHO target).
G. Physical inactivity: Approximately 3905 deaths will be
prevented or postponed, assuming that absolute
physical inactivity prevalence reduction will be 6%
(10% relative reduction by WHO target).
The largest contributions come from reductions in
salt intake, energy from saturated fat and increase in
F&V consumption (table 3, ﬁgure 2). For both scen-
arios, reductions in mean BMI, physical inactivity and
smoking prevalence made <15% contribution to
changes in CHD deaths in Turkey.
DISCUSSION
This study provided information by modelling the
impact of improvements in the burden of main risk
factors such as smoking, diabetes, physical inactivity,
BMI, consumption of saturated fat, salt and consump-
tion of F&V on avoidable CHD mortality in Turkey for
year 2025. We present the estimates for one year only;
beneﬁts would be expected in other years if the
improvements are made and sustained. Our modest
change scenario estimates suggest that if there is lower
mortality change, feasible risk factor improvements in
Turkey could prevent or postpone ∼25 600 deaths from
CHD by 2025, a reduction of ∼16% of CHD deaths
expected in 2025. However, more ideal changes in risk
factors could avoid about 46 000 CHD deaths, a reduc-
tion of ∼30% of CHD deaths expected in 2025.
Based on all scenarios, the most substantial contribu-
tions came from the changes in salt intake, energy
intake from saturated fat and F&V consumption. These
results were well supported by other modelling studies
performed in the UK.42 43 These three nutritional
changes in combination could result in 68–63% reduc-
tion in CHD deaths in Turkey in the year 2025. Other
modelling studies found that ∼20% and 40% of all pre-
mature CVD deaths might be averted by optimising
various dietary risk factors in the UK41 and USA,44
respectively. The even higher contribution of salt on
potential reductions of CHD mortality in Turkey com-
pared with other countries is due to very high baseline
intake of salt.34 Reductions in salt and saturated fat
intake have powerful impacts on blood pressure and
total cholesterol levels. As already demonstrated in many
countries (Finland, Mauritius, UK, USA and Ireland),
considerable CHD mortality reductions would come
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from decreases in blood total cholesterol and blood
pressure.45–49
High salt consumption (15 g/day) is an important
problem that can be ameliorated.35 Salt consumption
was lowered by about 15% in 7 years in the UK by a
national salt reduction programme which was consid-
ered to be a relatively weak intervention (relying mainly
on voluntary agreements with the food industry, rather
than more powerful legislative and ﬁscal policies).50
Greater falls in Turkey could be achieved by adopting
wider salt reduction strategies, including working with
the food industry, public health campaigns, monitoring
progress and sustaining the strategies.51 Approximately
70–80% of sodium consumption comes from processed
foods and ready meals in Western countries. However,
the most important sources of sodium in the diet are
sauces and adding salt in food preparation in Asian and
African countries.52 In Turkey, the most important
sources of sodium in diet are adding salt to food during
preparation (56%), bread (32%) and adding salt on
table (13%).35 Thus, a higher proportion of salt con-
sumption in Turkey is ‘discretionary’ (added during
cooking or eating) and potentially amenable to rapid
reduction. Turkish cuisine also includes salty tomato
paste that is added to home-made meals, salty pickles,
olives and salty cheese. Therefore, strategies to reduce
the salt in bread, remove salt from the table in restau-
rants and campaigns to inform the public about the
harms of salt may be more effective. The recent
National Salt Reduction Action Plan 2015 in Turkey has
adopted salt reduction strategies, including reducing the
amount of salt in bread and processed products by intro-
ducing legislation and to educate people to avoid
adding salt on the table through health promotion cam-
paigns.52 Recent modelling studies have estimated that
the most cost-effective options to reduce salt intake in
Turkey would be to implement three policy actions
simultaneously (reformulation of products, product
labelling and public health campaigns).53
The total daily energy intake from dietary SFA among
adults over 20 years was 12% in Turkey, only slightly
above the recommendations of the United Nation
Agriculture Organisation (10%).36 37 It is still important
to reduce consumption of SFA at a population level
because of the signiﬁcant impact on CHD deaths.
According to a very conservative estimate, a 1% reduc-
tion in saturated fat energy intake would result in ∼9800
fewer CHD deaths in Europe.54 The main effective strat-
egies suggested to reduce SFA intakes are to encourage
and support farmers to replace production from animal
fat to healthy foods, to work with the food industry on
product reformulation, reducing portion sizes, and to
increase availability of healthier foods such as F&V.55
This study highlights the potentially large impact that
increasing F&V intake could have on reducing CHD
deaths in Turkey. The EU and WHO recommend to
reach 5 and 7 portions/day F&V intake, respectively.40 41
Currently, daily F&V consumption (3.5 portions) is inad-
equate in Turkey,11 despite being a Mediterranean
country. Fast food consumption has become widespread
in urban areas, especially in children and young people.
Also, consumption of bread and grain products is
increasing due to socioeconomic problems and social
inequalities in Turkey. A comprehensive study showed
that increased F&V consumption up to an optimal level
of intake could reduce the global burden of CHD by
about 31%.56 There are some intervention strategies to
increase F&V consumption such as point-of-purchase
(POP) information, reduced prices and coupons,
increased availability, variety and convenience, promo-
tion and advertising.57 POP information is described as
the use of shelf labels and/or signage that speciﬁes
healthy food choices in grocery stores, based on estab-
lished criteria.57 Fresh F&V are more accessible and
Figure 1 Predicted decrease in
deaths, assuming no mortality in
2025. BMI, body mass index.
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relatively cheap in Turkey than other countries because
of ideal climate and widespread production. Thus, POP
information, promotion and advertising might be more
effective than other interventions in Turkey.
Increasing F&V consumption limits the consumption
of high-fat foods. For this reason, positive messages to
increase the consumption of F&V might be more effect-
ive than the messages that fatty foods should not be con-
sumed.58 In addition, high sugar-sweetened beverage
(SSB) consumption increases with high salt and fat con-
sumption. SSB consumption is one of the main causes
of obesity and diabetes. Hence, SSB should be replaced
with fresh F&V. There are some strategies to encourage
low salt, sugar and fat levels among food products in the
framework of the Turkey Healthy Diet and Active Life
Program.59 Turkey has banned the sale of SSBs and
high-calorie foods such as fried foods and crisps in elem-
entary schools. Replacement of these harmful products
by selling healthy foods such as milk, yoghurt and fruit
was recommended by the MoH.21
Some risk factors such as prevalence of DM and mean
BMI values were increasing rapidly in Turkey,21 where
they caused 9000 additional deaths in 2008.11 In our
case, we might have underestimated the 2025 death
rates as we did not take into account the impact of
increasing trends in DM and BMI on CHD mortality. It
is also likely that the contrasting trend of these factors
might cancel out much of the beneﬁts that would be
attained from improvements in other risk factors.
Hence, it calls for a better application of public health
policies on reducing burden of DM and high BMI, as
well as working to accelerate positive trends in salt,
smoking and physical inactivity.
Owing to the high prevalence of diabetes, obesity and
physical inactivity in Turkey,6 the MoH has action plans
for preventing obesity, physical inactivity and diabetes,
named the ‘Obesity Prevention and Control Program of
Turkey’ and ‘Diabetes Prevention and Control
Program’.21 The MoH aims to increase the number of
environments suitable for physical activity in the commu-
nity.59 Environmental regulations are needed to achieve
this goal by cooperating with municipalities. However,
there is neither sufﬁcient political will nor resources to
implement this across the country. Despite compulsory
increased physical activity and low energy intake in Cuba
for 4 years, the mean BMI of population decreased by
only 1.5 units;60 to date, sustained falls in BMI have been
hard to achieve at a population level.
The prevalence of smoking in adults signiﬁcantly
decreased by 13% between 2008 and 2012, due to the
regulations related with Framework Convention on
Tobacco Control in Turkey.19 Turkey implemented all
MPOWER strategies,61 and it is regarded as one of the
most successful countries in battling against smoking.
The MoH is planning to prevent young people from
starting to smoke by increasing monitoring, supervision
and creating negative attitudes towards tobacco use in
society.62
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Strengths and limitations
Models are practical and helpful tools for policy devel-
opment. They merge and concurrently regard all data
from many different sources. The validated Turkish
IMPACT model was developed further in this study.11
Data were updated and additional components were
added to the model to translate reductions in salt intake
or energy from saturated fat intake into reductions in
SBP or total cholesterol, respectively. We also made a
cumulative adjustment for simultaneous risk factor
improvements (since a CHD death can only be pre-
vented once). This is not routinely implemented in
modelling studies.25 This is the ﬁrst comprehensive mod-
elling study that examines the impact of changes in mul-
tiple risk factors and healthy food consumption on CHD
mortality trends in Turkey.
The demographic information was obtained from the
census data that covered the whole country; the risk
factor trends were obtained from national epidemio-
logical studies. In the Turkish IMPACT model, we
assessed the potential maximum and minimum plausible
effects of risk factors using rigorous probabilistic sensitiv-
ity analyses which systematically examine the inﬂuence
of these uncertainties and the assumptions used in the
studies. We used plausible estimates for changes in risk
factor scenarios.
Our study has several potential limitations. The model
included only those adults aged 25–84 years because of
very limited data in older age groups. The lag times
were not explicitly considered in this model. We mea-
sured only deaths from CHD and disregarded ‘compet-
ing causes’ such as cancer. Trends in treatment uptakes
were not considered in this model, though they were
already high in previous studies11 and are unlikely to
deteriorate.
The risk/protective factors included in the study
(physical inactivity, dietary salt, saturated fat intake,
mean BMI levels, diabetes prevalence, smoking
prevalence and F&V consumption) are highly inter-
related. Some of the RRs or β coefﬁcients were not
adjusted for each factor due to the feature of the
studies. This might cause a relatively small overesti-
mation while calculating DPPs, after all cumulative
adjustments. Multivariate probabilistic sensitivity analyses
were conducted to deal with this limitation.
Conclusion
Only modest risk factor changes in salt, saturated fat and
F&V intake could prevent around 16 000 CHD deaths in
the year 2025 in Turkey, even assuming mortality con-
tinues to decline. The most impressive strategies in
recent years will be those affecting healthy food policies.
This model can be a useful tool to explore potential
beneﬁts of implementing certain strategies to prevent
the future burden of CHD. Implementation of
population-based, multisectoral interventions to encour-
age healthy food consumption should be scaled up.
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